EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Metabolomic Profiling of Carnitines Reveals Diagnostic Candidates in Postpartum Cardiomyopathy

Yasemin Behram Kandemir, İsmail Koyuncu, Veysel Tosun, Ünal Güntekin

Metabolites · 09.03.2026 · 16 (3) · 180

DOI: 10.3390/metabo16030180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 09.03.2026. Verfasst von Yasemin Behram Kandemir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Faculty of Medicine, İstanbul Aydın University, 34295 İstanbul, Turkey. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postpartum cardiomyopathy (PPCM) is a rare but life-threatening condition characterized by left ventricular dysfunction occurring in the peripartum period. Alterations in carnitine metabolism have been implicated in myocardial energy dysregulation, yet targeted metabolic profiling in PPCM remains limited.

Methods

We conducted a targeted metabolomics study comparing serum carnitine and acylcarnitine profiles between 40 PPCM patients and 40 age-matched healthy controls. Samples were analyzed using LC–MS/MS. Multivariate analyses (PCA and PLS-DA), univariate statistics (t-test, ANOVA, and Tukey’s HSD), and ROC curve analysis were applied to identify discriminatory metabolites and their diagnostic potential.

Results

PPCM patients showed significantly decreased free carnitine (C0, p < 0.001) and elevated short-chain acylcarnitines such as acetylcarnitine (C2, p < 0.001) and propionylcarnitine (C3, p < 0.001) compared to controls. Notably, C14:1 and C18:1 were significantly reduced, whereas C6DC was elevated in PPCM (p < 0.001). PLS-DA and VIP analyses highlighted C2, C6DC, and C16 as key discriminators between groups. ROC analysis confirmed limited but notable diagnostic performance for C2 (AUC = 0.633), C6DC (AUC = 0.635), and C16 (AUC = 0.623).

Conclusions

Our findings demonstrate that PPCM is associated with profound alterations in carnitine metabolism, particularly reductions in long-chain acylcarnitines and increases in short-chain species. Specific metabolites such as C2, C6DC, and C16 may serve as potential biomarker candidates for PPCM diagnosis and prognosis. These results highlight the utility of targeted metabolomics in uncovering novel metabolic signatures of cardiomyopathy.

Schlagwörter

Stichwörter der Autor:innen

LC–MS/MSacylcarnitinesbiomarkerscarnitinemetabolomicspostpartum cardiomyopathy

Autor:innen und Institutionen

  • Department of Anatomy, Faculty of Medicine, İstanbul Aydın University, 34295 İstanbul, Turkey.
  • Department of Medical Biochemistry, Faculty of Medicine, Harran University, 63200 Şanlıurfa, Turkey.
  • Department of Cardiology, Mehmet Akif İnan Training and Research Hospital, 63200 Şanlıurfa, Turkey.
  • Department of Cardiology, Faculty of Medicine, Akdeniz University, 07100 Antalya, Turkey.

Zitieren

APA

Kandemir, Y. B., Koyuncu, İ., Tosun, V., & Güntekin, Ü. (2026). Targeted Metabolomic Profiling of Carnitines Reveals Diagnostic Candidates in Postpartum Cardiomyopathy. Metabolites, 16(3), 180. https://doi.org/10.3390/metabo16030180

Vancouver

Kandemir YB, Koyuncu İ, Tosun V, Güntekin Ü. Targeted Metabolomic Profiling of Carnitines Reveals Diagnostic Candidates in Postpartum Cardiomyopathy. Metabolites. 2026;16(3):180. doi:10.3390/metabo16030180

BibTeX
@article{Kandemir2026,
  author = {Kandemir, Yasemin Behram and Koyuncu, İsmail and Tosun, Veysel and Güntekin, Ünal},
  title = {Targeted Metabolomic Profiling of Carnitines Reveals Diagnostic Candidates in Postpartum Cardiomyopathy},
  journal = {Metabolites},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {180},
  doi = {10.3390/metabo16030180}
}
Kostenlos starten →